Great and expected news. Very happy for existing and future patients.
The 50 patients are for phase 2a. I am trying to find what phase 2b of the trial will look like - can anyone give me a steer?
I know no SH wants to discuss upcoming CRs but with the next phase 2b of this trial not being catered for in the May CR, plus the US trial ia not funded, so I think the next CR is a matter of time - may be before the end of the year after the interim readouts? Mgmt and SHs would be hoping be hoping the stock is at least 20-25c prior to the raise.
No advice. My sentiment is continue to accumulate.
Ann: Sixth Confirmed Response in Pancreatic Cancer Trial, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $91.57M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $766.6K | 3.262M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 179879 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 402089 | 6 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |